Jennison Associates LLC 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-06 4:13 pm Sale | 2026-03-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Jennison Associates LLC | 1,712,124 4.000% | -466,456 (-21.41%) | Filing |
| 2024-11-12 09:12 am Purchase | 2024-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | Jennison Associates LLC | 2,178,580 5.700% | 2,178,580 (New Position) | Filing |